Related Experiment Video
Updated: May 17, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Limited generalizability and high risk of bias in multivariable models predicting conversion risk from mild cognitive
Robin Jeanna Vermeulen1, Vebjørn Andersson2, Jimmy Banken1
1Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.
Abstract:
Prediction models have been developed to identify mild cognitive impairment (MCI) cases likely to convert to dementia. This systematic review summarizes multi-source prediction models for MCI to dementia conversion. PubMed and Embase were searched for model development and validation studies from inception up to January 18 2024. Models were assessed for included predictors, predictive performance, risk of bias, and generalizability. 62 studies were included: 41 machine learning models, 11 regression models, and 5 disease state indexes. The number of predictors in the models ranged from 2 to 60; magnetic resonance imaging (MRI) and cognitive scores were the most common sources. Performance measures indicate reasonable predictive capabilities (area under the curve [AUC] range: 0.58-0.98, accuracy range: 66.1-96.3%); however, most studies are at high risk of bias and 47 studies lack external validation. Currently, no highly valid prediction model is available for MCI to dementia conversion risk due to limited generalizability and high risk of bias in most studies. HIGHLIGHTS: Numerous models have been developed to predict the likelihood of conversion to dementia in individuals with MCI. Prediction models seem to have a reasonably good performance in predicting conversion to dementia, however, external validation and generalizability is often lacking. There is no prediction model available with a low risk for bias and that has been externally validated to accurately predict the risk of MCI to dementia conversion. For MCI to dementia conversion prediction models, more emphasis should be directed towards external validation, generalizability, and clinical applicability.
Insights
Numerous prediction models exist to identify mild cognitive impairment (MCI) cases likely to progress to dementia. However, most models lack external validation and have a high risk of bias, limiting their clinical applicability.
Area of Science:
- Neuroscience
- Gerontology
- Medical Informatics
Background:
- Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
- Accurate prediction of MCI to dementia conversion is crucial for timely intervention and management.
- Existing prediction models vary in their development, validation, and data sources.
Purpose of the Study:
- To systematically review and summarize multi-source prediction models for MCI to dementia conversion.
- To assess the predictors, performance, risk of bias, and generalizability of these models.
- To identify gaps and provide recommendations for future research in MCI prediction.
Main Methods:
- Systematic literature search of PubMed and Embase databases up to January 18, 2024.
- Inclusion of model development and validation studies for MCI to dementia conversion.
- Assessment of models based on predictors, predictive performance (e.g., AUC, accuracy), risk of bias, and generalizability.
Main Results:
- 62 studies were included, comprising 41 machine learning, 11 regression models, and 5 disease state indexes.
- Common predictors included magnetic resonance imaging (MRI) and cognitive scores; models used 2 to 60 predictors.
- Models demonstrated reasonable predictive capabilities (AUC: 0.58-0.98, accuracy: 66.1-96.3%), but most studies had high risk of bias and lacked external validation (47 studies).
Conclusions:
- No current prediction model for MCI to dementia conversion is highly valid due to limited generalizability and high risk of bias.
- While models show promising performance, significant limitations in external validation and generalizability persist.
- Future efforts must prioritize external validation, generalizability, and clinical applicability for robust MCI to dementia prediction models.
Related Concept Videos
Bias in Epidemiological Studies
Confounding in Epidemiological Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...
Relative Risk
Reliability and Validity

